Search

Your search keyword '"Davi, Frédéric"' showing total 373 results

Search Constraints

Start Over You searched for: Author "Davi, Frédéric" Remove constraint Author: "Davi, Frédéric"
373 results on '"Davi, Frédéric"'

Search Results

1. Circulating tumor cells in Waldenström macroglobulinemia

3. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis

4. Detecting measurable residual disease beyond 10−4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL

5. EuroClonality-NGS recommendations for evaluation of B cell clonality analysis by next-generation sequencing – a structured approach with the DEPART algorithm

7. Epstein-Barr Virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments

8. The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants

9. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

10. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

11. Artificial intelligence classifies and predicts the outcome of primary CNS and nodal large B-cell lymphomas

12. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

15. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS

16. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS

17. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

18. The Mutator Pathway Is a Feature of Immunodeficiency-Related Lymphomas

21. CombiningMYD88 L265Pmutation detection and clonality determination on CSF cellular and cell‐free DNA improves diagnosis of primary CNS lymphoma

22. Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing

24. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

25. The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots

26. Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL

27. Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.

28. Molecular Evidence for Antigen Drive in the Natural History of Mantle Cell Lymphoma

30. Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients

32. Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

35. Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell‐free DNA improves diagnosis of primary CNS lymphoma.

36. A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110

37. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency

38. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia:the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL

39. Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

41. Identification of Prognostic Factors in Post-Transplant Lymphoproliferative Disorders

43. TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia

44. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

45. Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study

47. Mast cell density and its clinical relevance in Waldenström's macroglobulinemia

50. Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC

Catalog

Books, media, physical & digital resources